Medicines A-to-Z

Octreotide injection#8.3

Amber - palliative care use only

Red - Oncology, acromegaly

Ofatumumab

For hospital use only

Ofatumumab (Kesimpta®)

Ofloxacin 0.3% eye drops

Oily phenol

Olanzapine orodispersible tablets

Specialist initiation only, ESCA

Olanzapine tablets

Specialist initiation only, ESCA

Olaparib (Lynparza®)

Olaratumab

For hospital use only

Olive oil ear drops

University Hospitals Birmingham NHS Foundation Trust

Drug name	NICE TAs	Comments
Octreotide injection#8.3		Amber - palliative care use only Red - Oncology, acromegaly
Ofatumumab	TA344 - Ofatumumab in combination with chlorambucil or bendamustine for untreated chronic lymphocytic leukaemia	For hospital use only
Ofatumumab (Kesimpta®)	TA699 - Ofatumumab for treating relapsing multiple sclerosis
Ofloxacin 0.3% eye drops
Oily phenol
Olanzapine orodispersible tablets		Specialist initiation only, ESCA
Olanzapine tablets		Specialist initiation only, ESCA
Olaparib (Lynparza®)	TA381 - Olaparib for maintenance treatment of relapsed, platinum-sensitive, BRCA mutation-positive ovarian, fallopian tube and peritoneal cancer after response to second-line or subsequent platinum-based chemotherapy TA598 - Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy TA620 - Olaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer TA693 - Olaparib plus bevacizumab for maintenance treatment of advanced ovarian, fallopian tube or primary peritoneal cancer TA908 - Olaparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal cancer after 2 or more courses of platinum-based chemotherapy
Olaratumab	TA465 - Olaratumab in combination with doxorubicin for treating advanced soft tissue sarcoma	For hospital use only
Olive oil ear drops